Literature DB >> 1645759

Modulation of IL-2- and IL-4-dependent human B cell proliferation by cyclic AMP.

A Vazquez1, M T Auffredou, P Galanaud, G Leca.   

Abstract

The second messenger cAMP is a modulator of cellular growth possessing both inhibitory and stimulatory properties. In this report, we show that IL-2- and IL-4-dependent DNA synthesis of anti-mu-activated human B cells is modulated in opposite ways by agents increasing intracellular levels of cAMP. Forskolin and 2'-O-dibutyriladenosine-3',5'-cyclic monophosphate had no proliferative effect by themselves. Nevertheless they decreased IL-2-driven proliferation and increased IL-4-mediated DNA synthesis. IL-4 and cAMP each inhibited the IL-2-dependent proliferation with similar patterns of reactivity. Both IL-4 and forskolin needed to be present during the first 48 h of culture to display inhibitory activity, and preactivation of B cells for 16 h with forskolin and IL-4 did not prevent further B cell response to IL-2. This suggests that cAMP and IL-4 directly interact with IL-2 signaling. In addition, we show that the cAMP-dependent protein kinase inhibitor N-(2-methylamino-ethyl)-5-iso-quinoline-sulfamide reversed the IL-4-inhibitory effect on IL-2-driven proliferation. Our data suggest that the IL-4-inhibitory signal to IL-2-driven human B cell proliferation involves cAMP-dependent protein kinase activation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1645759

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

1.  Identification of a cDNA for a human high-molecular-weight B-cell growth factor.

Authors:  J L Ambrus; J Pippin; A Joseph; C Xu; D Blumenthal; A Tamayo; K Claypool; D McCourt; A Srikiatchatochorn; R J Ford
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

2.  Studies on monoclonal anti-isotypic and anti-idiotypic antibodies against leukemia and myeloma: V. The effects of monoclonal antibodies and interferon on the levels of cyclic nucleotides in leukemic cell lines.

Authors:  G X Shen; J F Shao; T X Li; X L Wang; H F Zhu; N Su; Y Zhang; D F Yang
Journal:  J Tongji Med Univ       Date:  1992

3.  Interleukin-2 may enhance or inhibit antibody production by B cells depending on intracellular cAMP concentrations.

Authors:  D Dennig; S Mecheri; J H Bourhis; M K Hoffman
Journal:  Immunology       Date:  1992-10       Impact factor: 7.397

4.  Differential effects of interleukin-2 and interleukin-4 on immunomodulatory role of platelet-activating factor in human B cells.

Authors:  C L Patke; C G Green; W T Shearer
Journal:  Clin Diagn Lab Immunol       Date:  1994-07

5.  β2-Adrenergic Receptor Expression and Intracellular Signaling in B Cells Are Highly Dynamic during Collagen-Induced Arthritis.

Authors:  Nadine Honke; Clemens J Wiest; Georg Pongratz
Journal:  Biomedicines       Date:  2022-08-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.